Neo-adjuvant Abiraterone Prostate Study

NCT02160353 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

NETWORK

Sponsor class

Conditions

High Risk Localised Prostate Carcinoma

Interventions

DRUG: Abiraterone acetate, Prednisolone

Sponsor

Cancer Trials Ireland

Collaborators

[object Object]